| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/02/2004 | EP1373267A2 Non-nucleoside reverse transcriptase inhibitors |
| 01/02/2004 | EP1373266A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 01/02/2004 | EP1373265A1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 01/02/2004 | EP1373264A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors |
| 01/02/2004 | EP1373263A1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 01/02/2004 | EP1373262A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors |
| 01/02/2004 | EP1373261A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 01/02/2004 | EP1373259A1 Pyridazinone aldose reductase inhibitors |
| 01/02/2004 | EP1373258A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 01/02/2004 | EP1373257A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/02/2004 | EP1373256A1 Ccr5 antagonists useful for treating aids |
| 01/02/2004 | EP1373255A1 Process for the preparation of imidazole compounds |
| 01/02/2004 | EP1373254A1 New process |
| 01/02/2004 | EP1373253A1 Inhibitors of cyclin dependent kinases as anti-cancer agent |
| 01/02/2004 | EP1373252A1 Chemical derivatives and their use as anti-telomerase agent |
| 01/02/2004 | EP1373251A2 Non-imidazole compounds as histamine h3 antagonists |
| 01/02/2004 | EP1373250A1 Viologen linked acridine based molecule and process for the preparation thereof |
| 01/02/2004 | EP1373249A1 Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 01/02/2004 | EP1373248A1 Benzimidazol derivatives modulate chemokine receptors |
| 01/02/2004 | EP1373244A2 Substituted benzopyranones as telomerase inhibitors |
| 01/02/2004 | EP1373242A1 Dimeric isoflavones |
| 01/02/2004 | EP1373241A1 Method for producing optically active dihydropyrones |
| 01/02/2004 | EP1373240A2 Retinoid x receptor modulators |
| 01/02/2004 | EP1373234A2 Urokinase inhibitors |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373231A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors |
| 01/02/2004 | EP1373224A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 01/02/2004 | EP1373223A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373221A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373220A1 Benzimidazoles that are useful in treating sexual dysfunction |
| 01/02/2004 | EP1373219A1 Thiohydantoins and use thereof for treating diabetes |
| 01/02/2004 | EP1373218A1 Imidazolyl derivatives useful as histamine h3 receptor ligands |
| 01/02/2004 | EP1373217A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 01/02/2004 | EP1373216A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/02/2004 | EP1373215A1 Geldanamycin derivative and method of treating cancer using same |
| 01/02/2004 | EP1373211A1 Quinoline derivatives and their use as antibiotics |
| 01/02/2004 | EP1373207A1 Novel amlodipine camsylate and method for preparing thereof |
| 01/02/2004 | EP1373206A1 Aryl oxime-piperazines useful as ccr5 antagonists |
| 01/02/2004 | EP1373205A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 01/02/2004 | EP1373204A2 Heterocyclic compounds |
| 01/02/2004 | EP1373203A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 01/02/2004 | EP1373192A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1373188A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 01/02/2004 | EP1373185A2 Hydrophobic polyamine analogs and methods for their use |
| 01/02/2004 | EP1373182A1 Conjugated unsaturated glyceride mixtures and a method for producing the same |
| 01/02/2004 | EP1373158A2 Additives for building industry obtained from by-products and process for their production |
| 01/02/2004 | EP1372786A2 Cytoprotection by phosphotyrosine |
| 01/02/2004 | EP1372785A2 Compositions having improved bioavailability of eletriptan |
| 01/02/2004 | EP1372741A2 Morpholino imaging and therapy |
| 01/02/2004 | EP1372737A2 Preparation for the prophylaxis of restenosis |
| 01/02/2004 | EP1372732A1 Enzyme-activated cytostatic conjugates with integrin ligands |
| 01/02/2004 | EP1372728A1 Compositions comprising an o/w emulsion containing conjugated linoleic acid |
| 01/02/2004 | EP1372720A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 01/02/2004 | EP1372717A2 Combination treatment of pancreatic cancer |
| 01/02/2004 | EP1372701A2 Methods of therapy for hiv infection |
| 01/02/2004 | EP1372698A2 Use of cytokines of the tgf-beta superfamily for the treatment and diagnosis of skin related disorders |
| 01/02/2004 | EP1372697A2 Use of compounds modulating rxr-ppar heterodimer activity as medicine for treating hepatitis c, and corresponding screening method |
| 01/02/2004 | EP1372694A1 Liposome targeting of matrix metalloproteinase inhibitors |
| 01/02/2004 | EP1372692A2 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor |
| 01/02/2004 | EP1372689A2 Use of ikk-beta inhibitors and method for discovery of said inhibitors |
| 01/02/2004 | EP1372682A2 Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders |
| 01/02/2004 | EP1372681A1 Biologically active chloroform fraction of an extract obtained from a mangrove plant salvadora persica l |
| 01/02/2004 | EP1372680A1 Biologically active aqueous fraction of an extract obtained from a mangrove plant salvadora persica l |
| 01/02/2004 | EP1372679A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l |
| 01/02/2004 | EP1372677A1 Antitumor methods and compositions comprising sesquiterpene derivatives |
| 01/02/2004 | EP1372676A1 Pharmaceutical composition comprising copper, salicylic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection |
| 01/02/2004 | EP1372675A2 Ionene polymers and their use as antimicrobial agents |
| 01/02/2004 | EP1372674A2 Facially amphiphilic polymers as anti-infective agents |
| 01/02/2004 | EP1372673A2 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body |
| 01/02/2004 | EP1372672A1 Prophylactic teat treatment |
| 01/02/2004 | EP1372671A2 Methylated promoters for intraductal treatment of breast cancer |
| 01/02/2004 | EP1372670A1 Caloporoside derivatives, methods for the production thereof and their use |
| 01/02/2004 | EP1372669A1 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 01/02/2004 | EP1372668A2 Method of attenuating reactions to skin irritants |
| 01/02/2004 | EP1372667A2 Compositions for delivering bisphosphonates |
| 01/02/2004 | EP1372666A1 Use of fluticasone propionate in the treatment of diseases ameliorated by enhancement of epithelial / matrix adhesion such as asthma, cystic fibrosis and influenza |
| 01/02/2004 | EP1372665A2 Hormone replacement therapy method and its administration form |
| 01/02/2004 | EP1372664A1 Use of certain steroids for treatment of blood cell deficiencies |
| 01/02/2004 | EP1372663A1 Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives |
| 01/02/2004 | EP1372662A1 Taste masked liquid pharmaceutical compositions |
| 01/02/2004 | EP1372661A2 Methods of treating irritable bowel syndrome and functional dyspepsia |
| 01/02/2004 | EP1372660A2 A combination of fbpase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| 01/02/2004 | EP1372659A1 Substances for use in therapy of diseases that are caused by highly proliferative cells |
| 01/02/2004 | EP1372658A2 Methods of treating cancer using cyplastin combined with a dioxolane nucleoside such as troxacitabine |
| 01/02/2004 | EP1372657A2 A method of treating proliferative diseases using eg5 inhibitors |
| 01/02/2004 | EP1372656A1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/02/2004 | EP1372654A2 Quinoline inhibitors of hyak1 and hyak3 kinases |
| 01/02/2004 | EP1372653A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/02/2004 | EP1372652A2 Combination of a taxane and a cyclin-dependent kinase |
| 01/02/2004 | EP1372651A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |
| 01/02/2004 | EP1372650A2 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 01/02/2004 | EP1372649A2 Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors |
| 01/02/2004 | EP1372648A2 Tie2 receptor kinase inhibitors for treating angiogenic diseases |
| 01/02/2004 | EP1372647A2 Use of substituted imidazo 1,2-a]-pyridine compounds as medicaments |
| 01/02/2004 | EP1372646A2 Use of sugar phosphates, sugar phosphate analogues, amino acids, amino acid analoges for modulating transaminases and/or the association of p36/malate dehydrogenase |
| 01/02/2004 | EP1372645A1 Reconstitutable parenteral composition containing a cox-2 inhibitor |
| 01/02/2004 | EP1372644A2 Use of substituted imidazo 1,2-a]-pyridine-3-yl-amide and imidazo 1,2-a]-pyridine-3-yl-amine compounds as medicaments |
| 01/02/2004 | EP1372643A1 Pyrazolopyridines, process for their preparation and use as therapeutic compounds |